ID

39170

Beschreibung

Chinese Medicine on Deferring Dialysis Initiation; ODM derived from: https://clinicaltrials.gov/show/NCT02194946

Link

https://clinicaltrials.gov/show/NCT02194946

Stichworte

Versionen (1)
  1. 07.12.19 07.12.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

7. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility End-Stage Renal Disease NCT02194946

Englisch

Eligibility End-Stage Renal Disease NCT02194946

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18-75 years;
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
egfr ＜15 ml/min per 1.73 m2;
Beschreibung

Estimated Glomerular Filtration Rate

Datentyp

boolean

Alias
UMLS CUI [1]
C3811844
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
Beschreibung

Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0332197
yellow race.
Beschreibung

Racial group Yellow

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034510
UMLS CUI [1,2]
C0221205
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
Beschreibung

Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0011946
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0459914
UMLS CUI [2,3]
C0022646
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0302353
UMLS CUI [5]
C0546630
UMLS CUI [6,1]
C0017654
UMLS CUI [6,2]
C2964649
pregnant or lactating.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
Beschreibung

Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver

Datentyp

boolean

Alias
UMLS CUI [1]
C0184770
UMLS CUI [2]
C0017181
UMLS CUI [3]
C1619727
history of malignancy other than a successfully and completely treated carcinoma;
Beschreibung

Malignant Neoplasms | Exception Carcinoma Treated Completely

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007097
UMLS CUI [2,3]
C1522326
UMLS CUI [2,4]
C0205197
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
Beschreibung

Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C3714565
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0525058
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
Beschreibung

Glucocorticoids | Immunosuppressive Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0017710
UMLS CUI [2]
C0021081
participation in any other clinical trial;
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
known or suspected allergy to certain agents involved;
Beschreibung

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility End-Stage Renal Disease NCT02194946

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged 18-75 years;
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr ＜15 ml/min per 1.73 m2;
boolean
C3811844 (UMLS CUI [1])
Chronic Kidney Disease Biopsy | Chronic Kidney Disease Medical History | Diabetes Mellitus Absent
Item
non-diabetic ckd, which should be identified by biopsy or patients' medical histories.
boolean
C1561643 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1561643 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0011849 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Racial group Yellow
Item
yellow race.
boolean
C0034510 (UMLS CUI [1,1])
C0221205 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Indication Dialysis | Status post Conservative Treatment Kidney | Hemoglobin measurement | Serum potassium measurement | Carbon dioxide combining power measurement | Glomerular Filtration Rate CKD-EPI
Item
clinical indications of dialysis still occur after conservative kidney management for 1 week, which will be ruled out as hemoglobin < 70g/l; or serum potassium> 5.5mmol/l; or co2cp <13mmol/l; or epi-gfr≤5ml/min/1.73m2 ;
boolean
C3146298 (UMLS CUI [1,1])
C0011946 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0459914 (UMLS CUI [2,2])
C0022646 (UMLS CUI [2,3])
C0518015 (UMLS CUI [3])
C0302353 (UMLS CUI [4])
C0546630 (UMLS CUI [5])
C0017654 (UMLS CUI [6,1])
C2964649 (UMLS CUI [6,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Patient status determination, critical | Gastrointestinal Hemorrhage | Decompensated cirrhosis of liver
Item
critical status, such as alimentary tract hemorrhage or decompensated cirrhosis;
boolean
C0184770 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C1619727 (UMLS CUI [3])
Malignant Neoplasms | Exception Carcinoma Treated Completely
Item
history of malignancy other than a successfully and completely treated carcinoma;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007097 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0205197 (UMLS CUI [2,4])
Mental condition Interferes with Protocol Compliance | Individual Physical Condition Interferes with Protocol Compliance
Item
any condition (mental or physical) that would interfere with the patient's ability to comply with the study protocol;
boolean
C3840291 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3714565 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Glucocorticoids | Immunosuppressive Agents
Item
concurrent or current treatment with glucocorticoid or immunosuppressant agents in last 3 months;
boolean
C0017710 (UMLS CUI [1])
C0021081 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other clinical trial;
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs
Item
known or suspected allergy to certain agents involved;
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video